Clinical Trial

Do Intravaginal Devices Reduce Urinary Incontinence in Female Runners?

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated December 17, 2024 (before its estimated September 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
More than one in five females experience the embarrassment and shame of urine leakage while exercising and this urinary incontinence (UI) is a substantial barrier to exercise. As many as one in three females with UI report that they limit their physical activity due to incontinence: 11.6% by not exercising at all, 11.3% by exercising less and 12.4% by changing the type of exercise they perform. It is imperative to look for alternatives to manage this condition, as it is a key reason why females abandon the very physical exercise that is necessary to maintain or improve their physical and mental health and their quality of life. While there is Grade A evidence for pelvic floor muscle training and some evidence for intravaginal pessaries to reduce symptoms of UI in general female populations, no study has evaluated the impact of conservative interventions specifically on UI experienced predominantly during running.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2023-03-06; most recent amendment 2024-12-11.
Status change: Not Yet Recruiting → Recruiting 2023-05-06
Trial Details
NCT Number NCT05773378
Lead Sponsor University of Ottawa
Conditions Urinary Incontinence
Enrollment 90 participants
Start Date 2023-04-14
Primary Completion 2025-09-01 (estimated)
Study Completion 2025-09-01 (estimated)
Updated on ClinicalTrials.gov 2024-12-17